GENOME EDITING OF HUMAN NEURAL STEM CELLS USING NUCLEASES
The invention provides methods for generating a genetically modified human neural stem cell, genetically modified human neural stem cells, and pharmaceutical compositions comprising the genetically modified human neural stem cells. Also provided are associated kits. The invention also provides methods for preventing or treating a neurodegenerative disease or a neurological injury in a human subject using genetically modified human neural stem cells..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 10. Aug. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
PORTEUS MATTHEW H [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-08-10, Last update posted on www.tib.eu: 2023-08-23, Last updated: 2023-09-01 |
|---|
| Patentnummer: |
US2023250423 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA017886473 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA017886473 | ||
| 003 | DE-627 | ||
| 005 | 20230901061240.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230829s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA017886473 | ||
| 035 | |a (EPA)US2023250423 | ||
| 035 | |a (EPA)60037918 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a PORTEUS MATTHEW H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a GENOME EDITING OF HUMAN NEURAL STEM CELLS USING NUCLEASES |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-08-10, Last update posted on www.tib.eu: 2023-08-23, Last updated: 2023-09-01 | ||
| 520 | |a The invention provides methods for generating a genetically modified human neural stem cell, genetically modified human neural stem cells, and pharmaceutical compositions comprising the genetically modified human neural stem cells. Also provided are associated kits. The invention also provides methods for preventing or treating a neurodegenerative disease or a neurological injury in a human subject using genetically modified human neural stem cells. | ||
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a bio | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a KILDEBECK ERIC J |4 aut | |
| 700 | 0 | |a DEVER DANIEL P |4 aut | |
| 700 | 0 | |a CLARK JOSEPH T |4 aut | |
| 700 | 0 | |a TSUKAMOTO ANN |4 aut | |
| 700 | 0 | |a UCHIDA NOBUKO |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 10. Aug. |
| 773 | 1 | 8 | |g year:2023 |g day:10 |g month:08 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/60037918/publication/US2023250423A1?q=US2023250423 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 10 |c 08 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 10 |c 08 | ||